Stoke Therapeutics, Inc. (STOK)

35.48 +0.83 (+2.40%) USD  |  NASDAQ  |  Mar 06, 16:00
35.50 +0.02 (+0.06%) After-Hours: 20:00
More

Stoke Therapeutics Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for STOK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
Biogen, Inc. Upgrade
Krystal Biotech, Inc. Upgrade
Scholar Rock Holding Corp. Upgrade
Zymeworks, Inc. Upgrade
Moderna, Inc. Upgrade